All sponsors

United Therapeutics $UTHR

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING3
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO60%

Delay Index: of 5 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +8.0 months). See all sponsors →

Open United Therapeutics on the live radar map → 📅 $UTHR readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Ralinepag
NCT03683186
P3Enrolling by invitationPAH; Pulmonary Hypertension10002026-12 (+27 mo)
Inhaled Treprostinil
NCT05943535
P3RecruitingProgressive Pulmonary Fibrosis; Interstitial Lung Disease6982027-11
SUMMIT 201
NCT07923591
P2Not yet recruitingPulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease402028-05
EXPAND
NCT06878560
P1/2RecruitingESRD (End-Stage Renal Disease); Kidney Transplantation502028-10 (+4 mo)
EXTEND
NCT07224763
P1/2RecruitingESRD (End-Stage Renal Disease); Kidney Transplantation502029-11 (+8 mo)
TETON-OLE
NCT04905693
P3Enrolling by invitationIdiopathic Pulmonary Fibrosis; Interstitial Lung Disease18502029-12 (+67 mo)
SUMMIT OLE
NCT07923526
P2/3Not yet recruitingPulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease4002034-09